FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5                       
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Ruiz-Caban Wilfredo		 2. Issuer Name and Ticker or Trading Symbol

CONMED CORP [ CNMD ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                    _____ 10% Owner
__X__ Officer (give title below)    _____ Other (specify below)
EVP QA, RA and Operations
(Last)          (First)          (Middle)

C/O CONMED CORPORATION, 525 FRENCH ROAD		 3. Date of Earliest Transaction (MM/DD/YYYY)

6/5/2020
(Street)

UTICA, NY 13502
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
 6. Individual or Joint/Group Filing (Check Applicable Line)

_X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 6/5/2020  M  23360 A$39.87 25592 D  
Common Stock 6/5/2020  F  16555 D$81.29 9037 D  
Common Stock 6/5/2020  M  18000 A$41.93 27037 D  
Common Stock 6/5/2020  F  13167 D$81.03 13870 D  
Common Stock 6/5/2020  S  9919 D$82.02 (1)3951 D  

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)		2. Conversion or Exercise Price of Derivative Security3. Trans. Date3A. Deemed Execution Date, if any4. Trans. Code
(Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)		8. Price of Derivative Security
(Instr. 5)		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Options To Purchase Common Stock $39.87 6/5/2020  M     23360   (2)3/1/2026 Common Stock 23360 $0 5840 D  
Options To Purchase Common Stock $41.93 6/5/2020  M     18000   (2)3/1/2027 Common Stock 18000 $0 12000 D  
Explanation of Responses:
(1) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.56 to $82.74. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
(2) The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period
Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
Ruiz-Caban Wilfredo
C/O CONMED CORPORATION
525 FRENCH ROAD
UTICA, NY 13502

EVP QA, RA and Operations
Signatures
Sarah M. Oliker for Wilfredo Ruiz-Caban by Power of Attorney6/8/2020
**Signature of Reporting PersonDate
CONMED (NASDAQ:CNMD)
Gráfico Histórico do Ativo
De Out 2024 até Nov 2024 Click aqui para mais gráficos CONMED.
CONMED (NASDAQ:CNMD)
Gráfico Histórico do Ativo
De Nov 2023 até Nov 2024 Click aqui para mais gráficos CONMED.